Lin Patrick 4
4 · Processa Pharmaceuticals, Inc. · Filed Jan 29, 2025
Insider Transaction Report
Form 4
Lin Patrick
Chief Business - Strategy Off
Transactions
- Purchase
Common Stock
2025-01-27$0.80/sh+43,500$34,691→ 43,500 total(indirect: By Trust)
Holdings
- 29,059
Common Stock